Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)
Convoca: Pfizer Inc
Termini: 25/11/2026
Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)
on 13 d'octubre de 2026
with No hi ha comentaris

Deixa un comentari